tetano
Editor, Senior Moderator
Circ J
. 2021 May 15.
doi: 10.1253/circj.CJ-21-0219. Online ahead of print.
Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019
Satoshi Ide[SUP] 1 2 [/SUP], Hiromasa Hayama[SUP] 3 [/SUP], Yusuke Asai[SUP] 4 [/SUP], Mari Terada[SUP] 1 [/SUP], Hidetoshi Nomoto[SUP] 1 2 [/SUP], Satoshi Kutsuna[SUP] 1 [/SUP], Norio Ohmagari[SUP] 1 2 [/SUP], Yukio Hiroi[SUP] 3 [/SUP]
Affiliations
Abstract
Background: Several studies have reported elevated troponin levels in coronavirus disease 2019 (COVID-19) patients, so we investigated myocardial damage by measuring high-sensitivity troponin T (hsTnT) levels and analyzed the relationship with comorbidities.Methods and Results:Of 209 patients who recently recovered from COVID-19, 65% had an elevated hsTnT level that was higher than levels in patients with acute phase infection despite most patients (79%) having a mild illness. The hsTnT levels correlated with disease severity, sex, comorbidities, and ACEi and ARB use.
Conclusions: Myocardial damage occurs in the recovery phase of COVID-19, and its evaluation, regardless of patient age, should be considered.
Keywords: Coronavirus disease 2019 (COVID-19); High-sensitivity troponin T; Myocardial damage.
. 2021 May 15.
doi: 10.1253/circj.CJ-21-0219. Online ahead of print.
Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019
Satoshi Ide[SUP] 1 2 [/SUP], Hiromasa Hayama[SUP] 3 [/SUP], Yusuke Asai[SUP] 4 [/SUP], Mari Terada[SUP] 1 [/SUP], Hidetoshi Nomoto[SUP] 1 2 [/SUP], Satoshi Kutsuna[SUP] 1 [/SUP], Norio Ohmagari[SUP] 1 2 [/SUP], Yukio Hiroi[SUP] 3 [/SUP]
Affiliations
- PMID: 33994409
- DOI: 10.1253/circj.CJ-21-0219
Abstract
Background: Several studies have reported elevated troponin levels in coronavirus disease 2019 (COVID-19) patients, so we investigated myocardial damage by measuring high-sensitivity troponin T (hsTnT) levels and analyzed the relationship with comorbidities.Methods and Results:Of 209 patients who recently recovered from COVID-19, 65% had an elevated hsTnT level that was higher than levels in patients with acute phase infection despite most patients (79%) having a mild illness. The hsTnT levels correlated with disease severity, sex, comorbidities, and ACEi and ARB use.
Conclusions: Myocardial damage occurs in the recovery phase of COVID-19, and its evaluation, regardless of patient age, should be considered.
Keywords: Coronavirus disease 2019 (COVID-19); High-sensitivity troponin T; Myocardial damage.